Analyst Rating Update on ZELTIQ Aesthetics (ZLTQ)

ZELTIQ Aesthetics (NASDAQ:ZLTQ) : Zacks Investment Research ranks ZELTIQ Aesthetics (NASDAQ:ZLTQ) as 3, which is a Hold recommendation. 8 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 9 research analysts is 1.22, which indicates as a Strong Buy.

ZELTIQ Aesthetics (NASDAQ:ZLTQ) : The consensus price target for ZELTIQ Aesthetics (NASDAQ:ZLTQ) is $38 for the short term with a standard deviation of $3.7. The most optimist securities analyst among the 8 who monitor the stock believes that the stock can reach $43, however, the pessimist price target for the company is $32.

For the current week, the company shares have a recommendation consensus of Buy.

ZELTIQ Aesthetics (NASDAQ:ZLTQ): stock turned positive on Tuesday. Though the stock opened at $26.01, the bulls momentum made the stock top out at $26.6099 level for the day. The stock recorded a low of $25.92 and closed the trading day at $26.35, in the green by 2.93%. The total traded volume for the day was 786,888. The stock had closed at $25.6 in the previous days trading.

In an insider trading activity,The director of Zeltiq Aesthetics Inc, Fisher Mary sold 1,863 shares at $30 on April 13, 2016. The Insider selling transaction had a total value worth of $55,890. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.